Skip to main content
Immunovia logo

Immunovia — Investor Relations & Filings

Ticker · IMMNOV ISIN · SE0006091997 LEI · 549300KHWL6KK1XGUO81 ST Human health and social work activities
Filings indexed 377 across all filing types
Latest filing 2024-04-23 Major Shareholding Noti…
Country SE Sweden
Listing ST IMMNOV

About Immunovia

https://immunovia.com/

Immunovia is a diagnostics company focused on revolutionizing the early detection of pancreatic cancer. Its primary product is the PancreaSure test, a simple blood test designed to detect pancreatic cancer at Stage 1 and 2 with high accuracy. The test is intended for annual surveillance of individuals at elevated risk due to family history or genetic mutations. PancreaSure functions by detecting proteins and other biomarkers indicative of pancreatic cancer growth. The company's mission is to improve survival rates for this highly lethal cancer by enabling diagnosis at its earliest, most treatable stages, offering a convenient alternative to invasive imaging procedures.

Recent filings

Filing Released Lang Actions
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding ('Major shareholding notification') for Immunovia AB (publ), specifically reporting a 'Sell' transaction by Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension. It explicitly lists the 'Before the transaction' and 'After the transaction' quantities, percentages, and the reason for notification ('Flaggning sker för passerat tröskelvärde beträffande det aggregerade innehavet' - Flagging occurs due to crossing the threshold regarding the aggregate holding). This content directly matches the definition of a Major Shareholding Notification, which corresponds to code MRQ.
2024-04-23 English
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 98% confidence The document details a change in shareholding percentage for an entity ('Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension') in 'Immunovia AB (publ)'. It explicitly states 'Reason for major shareholding notification Buy' and shows the resulting share quantities and percentages, indicating a notification when a significant ownership threshold (10%) was crossed. This directly corresponds to the definition of a Major Shareholding Notification.
2024-04-11 English
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 98% confidence The document details a change in shareholding, specifically a 'Sell' transaction by a holder ('Avanza Bank Holding AB för Försäkringsaktiebolaget Avanza Pension'), resulting in a new percentage of voting rights (9.77189%). It explicitly mentions 'Reason for major shareholding notification' and provides detailed tables showing 'Before the transaction' and 'After the transaction' holdings, including shares and voting rights percentages. This structure is characteristic of a Major Shareholding Notification, which in the provided definitions corresponds to the Major Shareholding Notification code (MRQ). The document is not an earnings release (ER), a full annual report (10-K), or a director's dealing (DIRS), but specifically tracks significant ownership changes.
2024-04-10 English
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding ('Holder' is Avanza Bank Holding AB for a pension fund) involving a specific number of shares (4,530,742) and the resulting percentage of voting rights (10.0044%). The transaction reason is explicitly stated as 'Reason for major shareholding notification Buy'. This structure—reporting the 'Before' and 'After' quantities and percentages of ownership crossing a threshold (implied by the notification format)—is characteristic of a Major Shareholding Notification. This aligns with the definition for 'Major Shareholding Notification' (MRQ). The document is short and contains specific regulatory reporting details, confirming it is the notification itself, not an announcement of a report.
2024-04-09 English
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 99% confidence The document details a change in shareholding for Immunovia AB (publ) by Avanza Bank Holding AB for Försäkringsaktiebolaget Avanza Pension. It explicitly states the 'Reason for major shareholding notification Buy' and provides the 'Before the transaction' and 'After the transaction' details, including the new number of shares (4,460,354) and the resulting percentage (9.84897 %). This structure, focusing on crossing a threshold ('Flaggning sker för passerat tröskelvärde'), is characteristic of a Major Shareholding Notification. This aligns with the definition for 'Major Shareholding Notification' (Code: MRQ). The document length is short (3505 chars), but the content is the notification itself, not an announcement of a report.
2024-03-25 English
Major Shareholding Notification 2024
Major Shareholding Notification Classification · 98% confidence The document details a change in shareholding, specifically a 'Reason for major shareholding notification Sell' by Avanza Bank Holding AB for Avanza Pension. It explicitly lists the 'Before the transaction' and 'After the transaction' holdings, including the number of shares and the resulting percentage (9.70639%). This structure is characteristic of a notification regarding a significant change in ownership, which corresponds to the Major Shareholding Notification category. The document is short and contains specific transactional data, not a comprehensive annual or interim report. Therefore, the classification is MRQ (Major Shareholding Notification).
2024-03-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.